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Remarkable progress has been made in recent years in the treatment of acute ischemic stroke with the wider imple-
mentation of systemic and endovascular reperfusion therapies.1 
However, some patients may remain functionally dependent or 
die despite these interventions as the result of complications. 
Hemorrhagic transformation (HT), or bleeding into an area 
of ischemic brain, ranges from small petechiae to large par-
enchymatal hematomas.2 HT occurs in ≈12% of patients with 
ischemic stroke,3 but the risk increases to 26% after revascular-
ization therapies.4 HT is considered clinically relevant when it 
becomes symptomatic (symptomatic intracerebral hemorrhage 
[sICH]), which occurs in ≈3% of patients receiving systemic 
thrombolysis5 and 5% of patients treated with combined intra-
venous and intra-arterial therapy.4 The overall rate of sICH after 
mechanical thrombectomy is 4.4%,6 but it may increase up to 
11.3% when multiple device passes are required to achieve 
recanalization.7 Several clinical features, blood markers, 
genetic factors, and neuroimaging findings have been associ-
ated with HT in patients with ischemic stroke.8,9 HT is more fre-
quent after large infarctions,3,5,8–10 and critical determinants are 
severe damage of the vascular endothelium and the blood-brain 
barrier.8,11,12 Yet, better understanding of the mechanisms under-
lying HT is of utmost clinical relevance because it may lead 
to identifying more sensitive predictors and new therapeutic 
strategies to minimize the burden of this serious complication.
Recent studies suggested that the neutrophil to lymphocyte 
ratio (NLR) predicted an increased risk of sICH after thrombo-
lytic therapy in patients with stroke.13 However, it is currently 
unknown whether there is a causal association between neutro-
phils, NLR, and the hemorrhagic risk or, alternatively, whether 
changes in white blood cells follow the severity of stroke, or con-
current complications. Acute stroke induces lymphopenia by 
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Objective—Hemorrhagic transformation is a serious complication of ischemic stroke after recanalization therapies. This 
study aims to identify mechanisms underlying hemorrhagic transformation after cerebral ischemia/reperfusion.
Approach and Results—We used wild-type mice and Selplg−/− and Fut7−/− mice defective in P-selectin binding and lymphopenic 
Rag2−/− mice. We induced 30-minute or 45-minute ischemia by intraluminal occlusion of the middle cerebral artery and 
assessed hemorrhagic transformation at 48 hours with a hemorrhage grading score, histological means, brain hemoglobin 
content, or magnetic resonance imaging. We depleted platelets and adoptively transferred T cells of the different genotypes 
to lymphopenic mice. Interactions of T cells with platelets in blood were studied by flow cytometry and image stream 
technology. We show that platelet depletion increased the bleeding risk only after large infarcts. Lymphopenia predisposed 
to hemorrhagic transformation after severe stroke, and adoptive transfer of T cells prevented hemorrhagic transformation 
in lymphopenic mice. CD4+ memory T cells were the subset of T cells binding P-selectin and platelets through functional 
P-selectin glycoprotein ligand-1. Mice defective in P-selectin binding had a higher hemorrhagic score than wild-type mice. 
Adoptive transfer of T cells defective in P-selectin binding into lymphopenic mice did not prevent hemorrhagic transformation.
Conclusions—The study identifies lymphopenia as a previously unrecognized risk factor for secondary hemorrhagic 
transformation in mice after severe ischemic stroke. T cells prevent hemorrhagic transformation by their capacity to bind 
platelets through P-selectin. The results highlight the role of T cells in bridging immunity and hemostasis in ischemic stroke.
Visual Overview—An online visual overview is available for this article.  (Arterioscler Thromb Vasc Biol. 2018;38:1761-1771. 
DOI: 10.1161/ATVBAHA.118.311284.)
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mechanisms involving complex neurohormonal responses.14–17 
However, there is no information on whether stroke-induced 
lymphopenia increases the hemorrhagic risk.
Leukocytes interact with platelets18 though several mecha-
nisms, such as platelet P-selectin binding to PSGL-1 (P-selectin 
glycoprotein ligand-1 or CD162), which is expressed in neu-
trophils and T cells, but not B cells.19–21 Functional P-selectin 
binding epitopes in the PSGL-1 molecule require post-transla-
tional modifications involving protein glycosylation mediated 
by various glycosyltransferases, including Fut7 (fucosyltrans-
ferase 7).22 Expression of Fut7 in T lymphocytes is induc-
ible on activation and polarization of naive T cells, and it is 
required for T-cell migration into inflamed tissues.22–24 T cells 
exacerbate brain damage after cerebral ischemia/reperfusion 
because they facilitate platelet and leukocyte adhesion to the 
vessel wall and promote thromboinflammation.25,26
In our study, postischemic lymphopenia facilitated HT. We 
used Rag2−/− mice, which show severe lymphopenia because 
of lack of αβ and γδ T cells, B cells, and NKT (natural killer 
T cells) cells. These mice were prone to HT after severe isch-
emic stroke unless they were reconstituted with T cells. This 
study identified a new mechanism mediated by the PSGL-1/P-
selectin axis by which T cells and platelets prevent secondary 
HT after severe brain ischemia/reperfusion in mice.
Materials and Methods
The data that support the findings of this study are available from the 
corresponding author on reasonable request. An extended version of 
this section is available in the online-only Data Supplement.
Animals
We used adult (10–16 weeks) male mice on the C57BL/6J background 
(n=584). Mice included Rag2−/− mice (B6(Cg)-Rag2tm1.1Cgn/J, no. SN 
008449, The Jackson Laboratory) wild-type mice (no. SN 000664, 
Jaxmice), PSGL-1–deficient (Selplg−/−) mice, and Fut7−/− mice.27,28 
Animal work was conducted following the local and the European 
regulations. The ethical committee of the University of Barcelona 
(CEEA [Comité Ètic d’Experimentació Animal]) approved the exper-
imental procedures. Experimental animal work is reported in com-
pliance with the ARRIVE (Animal Research: Reporting of In Vivo 
Experiments) guidelines.
Brain Ischemia
Occlusion of the right middle cerebral artery (MCAo) was performed 
under isoflurane anesthesia using a monofilament (no. 701912PK5Re, 
Doccol Corporation, Sharon, MA), as described.29 Two days post-
ischemia, we assessed the neurological dysfunction with a neurologi-
cal score modified from a previously reported neuroscore.30
Drug Treatments
Treatment was randomly allocated and was administered in a blinded 
fashion. Ten minutes after reperfusion, mice received an intraperitoneal 
injection of rabbit anti-mouse platelet serum (15 μL diluted in saline 
to 200 μL; no. CLA31440, Cederlane) or the vehicle (saline).
Evaluation of HT
At 48 hours of reperfusion, mice were anesthetized with isoflurane 
and perfused through the heart with heparinized saline. The severity of 
brain hemorrhage was assessed in coronal brain sections (1-mm thick) 
of fresh tissue by giving scores (0–5, where 0 means absence of hemor-
rhage and 5 means large hematomas)31 and with histological measures.
Magnetic Resonance Imaging
The mouse brain was studied with magnetic resonance imaging (7T, 
BioSpec, Bruker) using ParaVision 6.0 software. Infarct volume was 
measured on images obtained with T2*-weighted turboRARE fast 
spin-echo.29 Cerebral blood flow was measured with a pulsed arterial 
spin labeling method. For assessment of brain bleeds, mice received 
a T2*-weighted magnetic resonance imaging scan using a gradient-
echo pulse sequence.
Immunofluorescence
Mice were perfused through the heart with heparinized saline fol-
lowed by 4% paraformaldehyde, and the brain was processed to obtain 
cryostat sections for immunofluorescence. Primary antibodies were 
rabbit polyclonal antibodies against pan-laminin or Glut-1 (facilitated 
glucose transporter, member 1) and rat monoclonal antibodies against 
CD41. Please see the Major Resources Table in the online-only Data 
Supplement. Images were obtained on a confocal microscope (TCS 
SPE-II, Leica Microsystems) with LAS software (Leica).
Isolation and Administration of T Cells for  
Adoptive Transfer
T cells were isolated from the spleen and the cervical and inguinal 
lymph nodes of donor mice through negative selection (Pan T-cell 
isolation kit-II mouse, no. 130-095-130, Miltenyi Biotech). Dead 
cells were removed (Dead cell removal kit, no. 130-090-101, Miltenyi 
Biotech), and viable T cells (15–20×106 cells) were administered 
intravenously to Rag2−/− mice the day before MCAo. Rag2−/− mice 
receiving adoptive transfer of T cells were compared with littermate 
Rag2−/− mice that did not receive cell administration.
Quantification of Brain Hemoglobin Content
Brain hemoglobin content was determined with a colorimetric assay 
(no. 700540, Cayman Chemicals).
Blood Cell Counts
Blood was collected from the vena cava in EDTA and was analyzed 
in a hematology system (ADVIA2120i, Siemens).
Flow Cytometry
Cell isolation from brain tissue was performed as described.32 Cells 
were incubated at 4°C for 10 minutes with FcBlock followed by pri-
mary antibodies. See the Major Resources Table in the online-only 
Data Supplement. Aqua (live/death, Molecular Probes) was used 
to gate on live cells. Brain cells and blood were studied in a BD 
FacsLSRII cytometer using the FacsDiva software (BD Biosciences). 
Data analysis was performed with FlowJo software (v10 FlowJo, 
LLC). P-selectin binding assay was performed using chimeric 
P-selectin/hIgM (human immunoglobulin M). Dynamic interactions 
of T cells with platelets were studied in diluted fresh whole blood, 
and cell conjugates were visualized with ImageStream MARKII 
technology (Amnis, EMD Millipore).
Platelet and T-Cell Conjugate Analysis
Diluted whole blood was prepared as described.33 Briefly, 50 µL of 
blood was diluted in 200 µL of Tris-buffered saline containing 20 U/mL 
Nonstandard Abbreviations and Acronyms
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of heparin. One milliliter of Tyrode’s buffer supplemented with 1.25 
mmol/L of CaCl
2
 was added. Fifty microliter were incubated for 20 
minutes with a mixture of antibodies. See the Major Resources Table in 
the online-only Data Supplement. Samples were immediately analyzed 
in a BD-FACS LSRII flow cytometer. For P-selectin binding assay, 105 
leukocytes were incubated with a mix of antibodies for 15 minutes at 
6°C and then with anti-hIgM fluorescein isothiocyanate for 15 min-
utes at 6°C. Cells were analyzed as above. For Amnis ImageStream 
analysis, whole diluted blood was stained with antibodies for 20 min-
utes at room temperature, red blood cells were lysed for 10 minutes at 
room temperature, and washed with Tyrode’s buffer. Data were col-
lected with INSPIRE software (EMD-Milipore) and was analyzed with 
IDEAS software (EMD-Milipore) using the wizard composite for CD3 
and CD41 to generate images of platelet-T cell conjugates.
Statistics
The statistical tests used in each experiment and n values are reported 
in the Figure legends.
Results
Platelet Depletion Increases the Hemorrhagic Risk  
Only in Large Infarcts
Reperfusion therapies are not recommended in ischemic 
stroke patients with low platelet counts because of a high 
risk of HT.34 Antiplatelet drugs also increase the risk of HT 
after reperfusion therapies, particularly in patients with large 
infarctions.9 To find out the contribution of platelets in pre-
venting hemorrhage secondary to brain ischemia, we treated 
mice with an antiplatelet serum that markedly reduced platelet 
numbers (Figure 1A). We induced different degrees of isch-
emic brain damage by MCAo for either 30 or 45 minutes. 
Forty-five–minute MCAo induced larger infarct volumes, as 
expected, and caused HT in some mice while HT was infre-
quent after 30-minute MCAo (Figure I in the online-only 
Data Supplement). Platelet depletion after induction of isch-
emia (Figure 1B) did not significantly increase brain bleeding 
after 30-minute MCAo while it produced large hematomas 
after 45-minute MCAo (Figure 1C and 1D). After 45-minute 
ischemia, we detected the presence of platelets in the isch-
emic brain tissue in different locations (Figure 1E), that is, 
intravascular platelets blocking the lumen of some capillar-
ies, platelets within parenchymal hemorrhages, or platelet 
clusters surrounding the abluminal side of the endothelium. 
Platelets surrounded blood vessels in zones with extravasated 
fibrin(ogen; Figure 1E), suggesting the formation of extravas-
cular hemostatic clots sealing the ruptured vessels.
Involvement of NLR, Neutrophils, and Lymphocytes  
in HT
A high NLR is associated with HT in patients with ischemic 
stroke treated with thrombolysis.13 We measured blood cell 
counts 48 hours after 45-minute ischemia to assess for the 
contribution of blood cells in HT in our stroke mouse models. 
Neutrophils tended to increase after ischemia, whereas lym-
phocyte numbers markedly decreased, in agreement with the 
reported stroke-induced lymphopenia,14–17 and the NLR as well 
as platelet numbers increased (Figure 2A). Infarct size was 
positively correlated to the hemorrhagic score (Figure 2B). 
Accordingly, examining infarct size in each category of HT 
score (Figure 2C) showed that mice with hemorrhages had 
larger infarctions and worse neurological deficits than mice 
devoid of bleeding (HT score=0) or with a few small petechiae 
(HT score=1; Figure 2D and 2E). Nonetheless, the mice with 
the highest hemorrhagic scores did not show the largest infarc-
tions (Figure 2D), suggesting that the magnitude of bleeding 
might be influenced by other factors in addition to infarct size. 
We then examined blood cell counts in relation to the degree 
of hemorrhage. We did not find apparent relationships between 
the degree of hemorrhage and neutrophil numbers or the NLR 
(Figure 2F and 2G). However, the most noticeable finding 
was that mice with the highest hemorrhagic scores showed 
lower lymphocyte counts (Figure 2H), and lymphocyte counts 
were inversely correlated with the HT score (Figure 2I). To 
account for infarct size and lymphocyte counts, we calculated 
the volume-to-lymphocyte ratio by dividing infarct size (% of 
hemispheric volume) by blood lymphocyte number (cells/nL). 
The volume-to-lymphocyte ratio progressively increased with 
increasing hemorrhagic score (Figure 2J). These results sug-
gest that the highest risk of bleeding occurs in large infarcts 
with the lowest lymphocyte counts.
Low T-Cell Numbers Increase HT After Severe  
Ischemia
Lymphopenic Rag−/− mice offer an experimental model 
to investigate whether low lymphocyte counts might be 
involved in HT. However, evidence shows that Rag−/− mice 
develop smaller lesions than the wild-type mice after tran-
sient ischemia,25,26 stressing that it is necessary to account 
for the extent of the infarct to address the relationship 
between lymphocytes and the risk of HT. Rag2−/− mice 
showed smaller infarct volumes than the wild-type mice 
after 30-minute ischemia (Figure II in the online-only Data 
Supplement). However, infarct volumes were similar in 
wild-type mice and Rag2−/− mice after 45-minute ischemia, 
and we did not detect differences in cerebral blood flow 
recovery after MCAo between genotypes (Figure II in the 
online-only Data Supplement). Nonetheless, after 45-min-
ute ischemia, the Rag2−/− mice seemed to bleed more, as 
assessed macroscopically in the tissue sections (Figure 3A) 
and microscopically in paraffin sections (Figure 3B). To 
find out whether this effect was attributable to the lack of T 
cells, we performed adoptive transfer of T cells to Rag2−/− 
mice the day before ischemia (see Figure III in the online-
only Data Supplement for viability and purity of injected 
T cells). Forty-eight hours after 45-minute MCAo, the 
lymphocyte counts×103 (mean±SD, n) were 0.830±0.386 
(ranging from 0.170 to 1.670; n=26) in wild-type mice; 
0.132±0.094 (ranging from 0.030 to 0.420; n=23) in Rag2−/− 
mice; and 0.279±0.204 (ranging from 0.070 to 0.880; 
n=13) in Rag2−/− mice that had received adoptive transfer 
of T cells. The increase of T cells after adoptive transfer 
was statistically significant (Mann-Whitney test, P=0.003). 
Notably, adoptive transfer of T cells lowered the HT score 
in Rag2−/− mice (Figure 3C; Figure IV in the online-only 
Data Supplement). We also quantified the brain hemoglobin 
content and performed T2*-weighted magnetic resonance 
imaging (Figure 3D and 3E). In all these measurements, 
adoptive transfer of T cells to the Rag2−/− mice consistently 
reduced the signs of secondary hemorrhage. In independent 
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groups of mice, we tested whether administration of T cells 
to Rag2−/− mice affected the size of the brain lesion and the 
neurological deficit. T cells increased infarct volume after 
30-minute MCAo but not after 45-minute MCAo (Figure 4). 
However, in the latter severe ischemia model, adoptive trans-
fer of T cells reduced the hemorrhagic score and attenuated 
the neurological deficits (Figure 4). Altogether, these results 
showed that T cells prevented HT after ischemic stroke in 
mice with marked lymphopenia.
Crosstalk of T Cells and Platelets
Platelets support interaction of platelet-binding T cells to the 
vessel wall,18 and T cells facilitate adhesion of leukocytes and 
platelets to the vascular endothelium after cerebral ischemia/
reperfusion.25 We found fewer platelet clusters around blood 
vessels of the ischemic tissue of Rag2−/− mice compared 
with wild-type mice but not after adoptive transfer of T cells 
(Figure 5A). The effect was not because of low platelet counts 
in these mice (mean±SD platelet number×103, wild-type 
Figure 1. Platelet depletion increases brain bleeding after severe ischemia but not mild ischemia. A, Time course of circulating plate-
lets after antiplatelet (AP) serum administration to control mice (n=3) to verify thrombocytopenia. B, Mice received antiplatelet serum 
or the vehicle (saline) intraperitoneally 10 min after reperfusion (reperf.) after 30-min (n=8 mice per group) or 45-min (n=7 mice per 
group) middle cerebral artery occlusion (MCAo). C and D, Fresh brain tissue sections were obtained at 48 h to assess for the pres-
ence of blood in the infarcted tissue. One section of each mouse is shown for illustrative purposes. Hemorrhagic transformation (HT) 
was assessed assigning a hemorrhagic score ranging from 0 (no hemorrhage) to 5 (large parenchymal hematoma). Platelet depletion 
did not significantly increase bleeding after 30-min MCAo (Mann-Whitney test, P=0.567). After 45-min MCAo, the hemorrhagic score 
tended to be higher in the platelet-depleted group (Mann-Whitney, P=0.092), but 1 mouse of each group did not bleed at all. However, 
within the mice showing some degree of blood in the brain tissue (n=6 per group), the hemorrhagic score was significantly higher in 
the platelet-depleted group (Mann-Whitney test, *P=0.035). E, After 45-min ischemia, platelets (CD41+, blue) are seen in the brain 
tissue in the vessel lumen (Intravascular), free in the brain parenchyma (parenchymal), and as clusters surrounding the vasculature 
(around vessels). Images are representative of 5 mice. Pan-laminin (red) shows the vessel basal lamina, and fibrin(ogen; green) shows 
vascular leakage. Scale bar, 15 µm.
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mice: 1240±205, n=8; Rag2−/− mice: 1430±296, n=7). We 
detected T cells within zones of platelet accumulations in 
the infarcted brain tissue of wild-type mice (Figure 5B) and 
hypothesized that an interaction of T cells with platelets might 
be involved in preventing HT after ischemic stroke. Specific 
subsets of T cells form conjugates with platelets in blood.21 
Accordingly, flow cytometry of blood showed ≈5% to 10% 
of T cells positive for CD41 (Figure VA in the online-only 
Figure 2. Low lymphocyte counts are associated with hemorrhagic transformation. Results of blood counts for control mice (n=12) 
and ischemic mice 48 h after 45-min middle cerebral artery occlusion (MCAo; n=26). A, After ischemia, neutrophils tended to increase 
(unpaired t test with Welch correction, P=0.053), lymphocyte numbers strongly decreased (***P<0.001), the neutrophil to lymphocyte ratio 
(NLR) increased (***P<0.001), and platelet numbers increased (**P=0.006; Mann-Whitney tests). B, The hemorrhagic score was positively 
correlated with infarct volume (Spearman r=0.541; P=0.004; n=26). C, We grouped ischemic mice (n=26) according to their hemorrhagic 
score, as illustrated with representative brain tissue sections. There were n=6 mice in each score category, excepting for score=4 with 
n=2 mice. D, Infarct volume was larger for mice showing bleeds (Kruskal-Wallis test P=0.017; Dunn test **P<0.01 vs score=0). E, Similar 
results were found for the neurological score (Kruskal-Wallis test P=0.078; Dunn test **P<0.01 vs score=0). F and G, Neutrophils and 
the NLR showed no apparent changes between hemorrhagic score categories (Kruskal-Wallis test P=0.238), but mice with hemorrhagic 
score=4 had low neutrophils (Dunn test, P<0.05 vs score=0). H, Lymphocytes tended to decrease progressively for higher hemorrhagic 
scores (Kruskal-Wallis test P=0.080; Dunn text *P<0.05 vs score=0). I, The hemorrhagic score was inversely correlated with lymphocyte 
number (Spearman r=−0.554; P=0.003; n=26). J, To account for infarct size and lymphocyte number, we calculated for each mouse 
the volume-to-lymphocyte ratio (VLR) as the ratio between infarct volume and the number of blood lymphocytes (cell counts/nL). VLR 
increased with increasing hemorrhagic score (Kruskal-Wallis test P=0.011; Dunn test *P<0.05 vs score=0. A, B, and I, Values for each 
mouse, and (D–H, J) represent group values as box and whiskers from min to max.
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Data Supplement), suggesting binding of activated platelets to 
a subset of T cells. Image stream technology combining high-
resolution microscopy with flow cytometry confirmed the 
presence of circulating T cell-platelet conjugates (Figure 5C).
Although the majority of blood T cells are CD162+, only 
a subset of them showed binding of a soluble P-selectin chi-
mera (Figure VB in the online-only Data Supplement) and 
formed platelet conjugates (Figure VC in the online-only Data 
Supplement). Accordingly, CD4+ memory T cells of wild-
type mice bound soluble P-selectin, whereas naïve T cells 
did not, and memory T cells deficient in Fut7 were unable to 
bind soluble P-selectin (Figure VIA in the online-only Data 
Supplement). Likewise, platelets mainly bound CD4+ mem-
ory T cells (Figure VIB in the online-only Data Supplement), 
whereas Fut7−/− or PSGL-1–deficient (Selplg−/−) memory T 
cells unable to bind P-selectin showed less platelet-T cell con-
jugates than the wild-type T cells (Figure 5D).
Active P-Selectin Binding Sites in T Cells Are 
Required to Prevent HT After Severe Ischemic Stroke
In vivo, PSGL-1–deficient mice (Selplg−/− mice) showed a 
higher hemorrhagic score than wild-type mice after 45-min-
ute ischemia (Figure 6A), suggesting that P-selectin bind-
ing was necessary to protect large infarcts from HT. To find 
out whether active P-selectin binding sites in T cells were 
involved in this effect, Rag2−/− mice received adoptive transfer 
of T cells obtained from either wild-type mice, Selplg−/− mice, 
or Fut7−/− mice. Selplg−/− and Fut7−/− T cells did not prevent 
Figure 3. Adoptive transfer of T cells prevents hemorrhagic transformation after severe ischemia in lymphopenic mice. Results were 
obtained 48 h after 45-min middle cerebral artery occlusion (MCAo). A, Representative 2,3,5-triphenyltetrazolium chloride brain sec-
tions illustrate the higher hemorrhagic scores in lymphopenic Rag2−/− mice than wild-type (wt) mice (n=10 per group) (Mann-Whitney 
test, *P=0.021). B, Carstair histological brain sections. Bottom, Magnifications of (middle). Rag2−/− mice (n=8) show larger hemorrhagic 
areas than wt mice (n=9; Mann-Whitney test, *P=0.026). C, Hemorrhage in fresh brain sections of independent groups of wt mice, 
Rag2−/− mice (R), and littermate Rag2−/− mice receiving adoptive transfer (AT) of T cells (R-AT) (n=10 per group). AT of T cells reduced the 
hemorrhagic score in Rag2−/− mice (Kruskal-Wallis test, P=0.045; Dunn test, &P<0.05; extended data and validation are shown in Fig-
ure IV in the online-only Data Supplement). D, Brain hemoglobin (Hb) content (ELISA assay) was higher in the ipsilateral hemisphere of 
Rag2−/− mice (n=14) than wt mice (n=17) but not after AT of T cells (n=10; 2-way ANOVA by group, P=0.047; and hemisphere, P<0.001; 
and Bonferroni test *P<0.05 vs wt mice; &&P<0.01 vs Rag2−/− mice). E, T2*-weighted magnetic resonance imaging (MRI) in wt mice 
(n=5), Rag2−/− mice (R) (n=7), and Rag2−/− mice receiving T cells (R-AT) (n=7) shows reduced hypointensity volumes (% of hemispheric 
volume) in the ischemic hemisphere of Rag2−/− mice after AT of T cells (Kruskal-Wallis test P=0.094; Dunn test, &P<0.05 vs R). The cor-
responding MRI infarct volume (T2 maps) did not differ between wt mice (35.7%±9.4%), Rag2−/− mice (38.1%±7.6%), and Rag2−/− mice 
with T-cell AT (36.4%±12.4%). Scale bar, 50 µm.
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HT after severe ischemia, in contrast to the effect of wild-
type T cells (Figure 6B; Figure VII in the online-only Data 
Supplement). These results demonstrate that P-selectin bind-
ing through functional PSGL-1 confers T cells the property to 
prevent HT after severe ischemia. Given that the subset of T 
cells with P-selectin–binding capacity are the memory T cells, 
our result suggests that memory T cells induce prohemostatic 
effects in large cerebral infarctions at risk of bleeding.
Discussion
The current best treatment for ischemic stroke is reperfu-
sion therapy with thrombolysis or mechanical thrombectomy 
in suitable patients. However, the benefits of these therapies 
may be hindered by complications, such as HT. HT occurs 
more frequently in patients with large infarctions,3,5,9 but little 
is known about the underlying mechanisms. This study dem-
onstrates that T cells reduce the risk of HT. It also confirms 
the relevance of infarct size as a critical factor that increases 
the hemorrhagic risk. Altogether, these results highlight the 
crosstalk between T cells and platelets bridging immunity and 
hemostasis to prevent HT after acute ischemic stroke.
Growing evidence supports the fact that platelets may con-
tribute to the endothelial barrier function by providing physical 
coverage to the damaged endothelium and thus prevent vascu-
lar leakage at sites of severe endothelial injury.35–37 Hence, our 
results support that platelets sealed the damaged vessels and 
reduced the leakage of blood to the ischemic brain parenchyma. 
This phenomenon was in part mediated by lymphocytes, given 
that lymphopenia favored HT in large infarctions but did not 
influence this risk of HT after small infarctions. Functional 
binding sites on PSGL-1 in T cells were necessary to prevent 
HT after severe ischemia. PSGL-1 interacts with selectins 
and is involved in leukocyte adhesion to the activated endo-
thelium and platelets.38,39 Lymphocytes and platelets interact 
through a complex crosstalk with functional consequences for 
both cell types.18 Memory CD4+ T cells are the circulating T 
cells that form conjugates with platelets. Platelet conjugation 
selectively enhances the adhesion of memory T cells to the 
endothelium of inflamed venules.39 This phenomenon might 
underlie the recognized role of T cells in promoting throm-
boinflammation and worsening brain damage after ischemia/
reperfusion.25,26 However, platelets also support P-selectin–
mediated adhesion of lymphocytes to the arterial wall when 
blood flow is disturbed40 and after exposure of subendothelial 
matrix proteins that can occur at arterial sites of injury.41 Our 
study suggests that memory T cells facilitate the formation of 
platelet plugs in the abluminal side of severely injured vessels. 
We found that the mechanism involves the PSGL-1/P-selectin 
axis, but identification of the precise molecular and cellular 
determinants of T cell–mediated platelet aggregation around 
the injured vessels will require more investigation.
The results highlight the intimate crosstalk between plate-
lets and lymphocytes and their double role in hemostasis and 
inflammation, which in the context of cerebral ischemia can 
bear predominantly negative (thrombo-inflammatory) or posi-
tive (hemostatic) effects, likely depending on the vascular bed, 
Figure 4. Effect of adoptive transfer of T cells on the outcome of brain ischemia. A and B, Rag2−/− mice received adoptive transfer (AT) of 
T cells the day before ischemia (Rag2−/− AT) or were untreated (Rag2−/−). Mice were subjected to either 30-min or 45-min middle cerebral 
artery occlusion (MCAo) and were studied at 48 h. The drop in cerebral blood flow (CBF) induced by MCAo was similar in all groups. 
A, After 30-min ischemia, the mice that received T cells (n=9) showed a larger infarct volume (%) than the mice that did not (n=7; t test, 
*P=0.017), but the differences in the neurological score were not statistically significant (Mann-Whitney test, P=0.186), and the hemor-
rhagic score did not change (Mann-Whitney test, P=0.402). B, After 45-min ischemia, the Rag2−/− mice with AT of T cells (n=10) showed 
an infarct volume similar to that of untreated Rag2−/− mice (n=12; t test, P=0.564). However, treatment with T cells improved the neurologi-
cal score (Mann-Whitney test, *P=0.017) and reduced the hemorrhagic score (Mann-Whitney test, *P=0.020).
1768  Arterioscler Thromb Vasc Biol  August 2018
the integrity of the vessels, and the risk of HT. T-cell prohemo-
static effects prevail in large infarctions at risk of experiencing 
HT. In contrast, detrimental effects of T cells become apparent 
in infarctions of mild or moderate size bearing a low risk of 
HT. This study identifies lymphopenia as a risk factor for HT 
of large infarctions, raising the question of whether T-cell 
Figure 5. Platelets in the ischemic brain tissue and platelet-T-cell conjugates in blood. A, Platelets (CD41+, blue) and vascular endothelial 
cells (Glut-1+ [facilitated glucose transporter, member 1], green) in the ischemic brain tissue 48 h after 45-min middle cerebral artery occlu-
sion representative of wild-type mice (n=5), Rag2−/− mice (n=5), and Rag2−/− receiving adoptive transfer of T cells (Rag2−/−AT; n=4). Assess-
ment of platelet distribution in the tissue shows less platelet clusters around blood vessels and more platelet groups in the parenchyma of 
Rag2−/− mice. Adoptive transfer of T cells to Rag2−/− mice prevents these effects. Values are the % of events in each location are the aver-
age of measures obtained by 2 independent observers. Two-way ANOVA by animal group and platelet location followed by the Bonferroni 
test (**P<0.01 and ***P<0.01 vs wild-type [wt] mice, &&&P<0.001 vs Rag2−/− mice). B, CD3+ T cells (green) are seen in the ischemic tissue 
near zones of CD41+ platelet aggregation (red). Nuclei are stained with To-Pro3 (blue). Scale bar, 10 µm. C, ImageStream analysis (Amnis) 
in whole fresh blood (n=4 control wild-type mice) allows direct visualization of platelets (CD41+, CD42a+) and activated platelets (CD62P+) 
bound to T cells. D, Plots show CD45+CD3+CD4+CD44+CD62L− effector memory T cells and illustrate reduced conjugates of platelets and 
CD4+ effector memory T cells in blood obtained from mice deficient in Fut7−/− (n=6) or PSGL-1 (P-selectin glycoprotein ligand 1; Selplg−/−; 
n=4) vs the blood of wt mice (n=10). The graph shows the results of platelet binding to naïve, central memory (cm), and effector memory 
(em) CD4+ T cells. For effector memory T cells, Kruskal-Wallis test P=0.024, Dunn test *P<0.05 vs wt cells. For central memory T cells, 
Kruskal-Wallis test P=0.09. Values in the plots and the bar graphs are the mean±SEM of the number of mice indicated above, and the value 
for each individual mouse is shown in the graphs. av indicates around the abluminal side of vessels; iv, intravascular; and p, parenchyma.
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administration after severe stroke could potentially reduce 
HT without exacerbating brain damage. Interestingly, a recent 
study reported that administration of regulatory T cells reduced 
HT induced by delayed treatment with tissue-type plasmino-
gen activator (tPA) in suture and embolic stroke mouse mod-
els, and the effect was related to attenuation of tPA-induced 
endothelial damage.42 PSGL-1 is involved in the suppressive 
activity of regulatory T cells, at least under certain experimen-
tal conditions.43 Further studies are needed to find out whether 
PSGL-1 mediates the effects of regulatory T cells in stroke.
Previous clinical studies have stressed the contribution of 
neutrophils and the NLR to the risk of HT after thromboly-
sis.13,44 In contrast, we did not find a clear relationship between 
neutrophil counts and the NLR with HT. A main difference 
between our study and those previous studies is that we did 
not use tPA. tPA promotes neutrophil transmigration to reper-
fused tissue via proteolytic activation of plasmin and gelatin-
ases,45 and it induces neutrophil degranulation.46 Furthermore, 
neutrophil extracellular traps impair tPA-induced thromboly-
sis.47 Therefore, the potentially damaging effect of neutrophils 
at the blood-brain barrier could be exaggerated by tPA.
Animals with large infarctions develop lymphopenia 
but the extent of the response shows some variation poten-
tially attributable to the magnitude of neurohormonal 
responses.17 Several lines of evidence suggest the possibility 
of neuroanatomical correlates of stroke-induced immunode-
pression48 that could explain why poststroke lymphopenia is 
more severe in some individuals than others despite similarly 
large lesion sizes. A limitation of our study is that it was per-
formed only in male mice. The results will require validation 
in female mice because of sex-dependent differences in the 
inflammatory response and contribution of immune cells to 
stroke outcome.49
Collectively, our results highlight the role of platelets and 
memory T lymphocytes attenuating HT of ischemic stroke by 
binding platelets through functional PSGL-1, thus identifying 
a new cellular and molecular target for secondary HT preven-
tion after ischemic stroke.
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Highlights
• Large ischemic brain lesions facilitate hemorrhagic transformation at reperfusion after ischemic stroke.
• Platelets seal leaky blood vessels and prevent hemorrhages secondary to severe brain ischemia/reperfusion.
• Lymphopenia increases the risk of hemorrhagic transformation after severe ischemic stroke.
• Transfer of T cells to lymphopenic mice prevents hemorrhagic transformation after brain ischemia/reperfusion.
• CD4 memory T cells bind platelets through the P-selectin glycoprotein ligand-1/P-selectin axis, and T cells unable to bind P-selectin do not 
prevent hemorrhagic transformation in lymphopenic mice.
